SKIN TUMOUR REMOVAL
Sun exposure is the direct cause of the development of skin tumours. There is about a 20-year delay before past sun-damage results in a tumour and there are 4 grades of tumour severity. Solar keratosis is the earliest development with scaly inflamed skin; next comes the locally invasive low-grade malignant BCC (Basal cell carcinoma); a step worse with malignancy is the SCC (Squamous cell carcinoma) which can spread to lymph nodes; and then there is the life threatening Malignant Melanoma. In addition, there are many entirely benign skin growths and lesions unrelated to the sun.
REASONS FOR SURGERY:
Dr Wallace performs Skin Tumour Removal surgery for the following reasons:
- To excise a known cancerous or pre-cancerous tumour
- To excise a suspicious lesion for pathological examination
- To excise a benign but cosmetically unacceptable growth or lesion
RISKS OF SURGERY:
This surgery is associated with a very low risk of complications. The specific risks of Skin Tumour Removal surgery of which you should be aware are:
Infection. The good blood supply to facial skin ensures that infection is very unlikely.
- Scarring. Some patients and certain skin types tend to produce thickened scars. Previous scars are a guide.
- Pigmentation. Certain skin types deposit pigment around a surgical scar.
Local Anaesthesia and outpatient Day Surgery is the routine for this procedure.
Dr. Wallace performs Skin Tumour Removal in a hospital or Day Surgery facility and occasionally, in the office. He injects the skin with Local Anaesthetic and marks out the proposed tumour excision. The tumour is excised and sent for pathological examination. Closure of the wound is with stitches and adhesive tapes. Closure can sometimes involve moving in a flap of adjacent skin.
Patients may go straight home. The wound should be kept dry. An appointment for suture removal is scheduled for 4 to 7 days post-op.
The vast majority Skin Tumour Removal wounds heal with an excellent cosmetic result and are curative of the problem. Some tumours require a revision procedure where the pathology report indicates inadequate clearance at the margins. Malignant tumours may require other treatments and close monitoring or follow-up.